Magle Chemoswed Holding AB Logo

Magle Chemoswed Holding AB

A CDMO serving the pharma and medical device industries from development to manufacturing.

MAGLE | ST

Overview

Corporate Details

ISIN(s):
SE0014401014 (+2 more)
LEI:
549300FNJZS6NGFB6M31
Country:
Sweden
Address:
Agneslundsvägen 27, 212 15 Malmö

Description

Magle Chemoswed Holding AB is a Contract Development and Manufacturing Organization (CDMO) serving the pharmaceutical and medical device industries. The company provides comprehensive services that support the entire product lifecycle, from initial development to commercial manufacturing. Core service areas include analytical development, process development, and solid-state chemistry. Its manufacturing operations are cGMP and ISO 13485 compliant, with specialized capabilities in lyophilization (freeze-drying), small-scale, semi-automated fill and finish services, and support for inhalation drug delivery systems. The company partners with clients to advance innovations from concept to finished product.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Magle Chemoswed Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Magle Chemoswed Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Magle Chemoswed Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-21 Stig Lökke Pedersen Other Other 384,000 11,520,000.00 SEK
2024-12-11 Martin Lidgard Other Buy 4,211 136,436.40 SEK
2024-12-05 Martin Lidgard Other Buy 632 21,740.80 SEK
2024-12-02 Martin Lidgard Other Buy 5,000 163,900.00 SEK

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.